Ausgabe 3/2006
Inhalt (7 Artikel)
Targeted therapies for solid tumors: is the dream becoming a reality?
Martine J. Piccart-Gebhart, Ahmad Awada
Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring
M. Gatineau, E. Dansin, F. Chomy, E. Lemarie, P. Nouyrigat, S. Oudard, R. Mouawad, A. Tisseron Carrasco, D. Khayat, O. Rixe
Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment
Erika Martinelli, Teresa Troiani, Floriana Morgillo, Maria Carmela Piccirillo, Katia Monaco, Maria Pia Morelli, Tina Cascone, Fortunato Ciardiello
Reovirus and other oncolytic viruses for the targeted treatment of cancer
L. Vidal, T. A. Yap, C. L. White, K. Twigger, M. Hingorani, V. Agrawal, S. B. Kaye, K. J. Harrington, J. S. de Bono
Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray
Gerhard S. Mundinger, Virginia Espina, Lance A. Liotta, Emanuel F. Petricoin III, Katherine R. Calvo
Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib
Y. Mishima, Y. Terui, K. Takeuchi, E. Nagasaki, M. Yokoyama, N. Mizunuma, S. Takahashi, K. Yamada, T. Fukunaga, J. Yamamoto, T. Yamaguchi, Y. Kato, K. Hatake
Hypertension and targeted therapy
Simon Chowdhury, James F. Spicer, Peter G. Harper